Recent topics in NMR imaging and MRI

Magnetic Resonance in Medical Sciences

Volumn 1, Issue 1, 2002, Pages 38-49

  Watanabe, Tokuko ^a  

^a JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Contrast agent; MRI; NMR imaging; Review

Indexed keywords

CONTRAST MEDIUM;

METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REVIEW;

CONTRAST MEDIA; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 24144439168     PISSN: 13473182     EISSN: 18802206     Source Type: Journal    
DOI: 10.2463/mrms.1.38     Document Type: Review

References (70)

1. Williams SCR, NMR imaging. A Specialist Periodical Report on NMR, 1992;21:415-454, 1993; 22:416-453, 1994;23:407-438, 1995;24:444-468, 1996;25:429-454, Royal Society of Chemistry, Cambridge, UK
2. Watanabe T, NMR imaging. A Specialist Periodical Report on NMR, 1997;26:447-454, 1998; 27:431-457, 1999;28:468-484, 2000;29:509-533, 2001;30:453-476, Royal Society of Chemistry, Cambridge, UK
3. Huerlimann MD, Carr-Purcell sequences with composite pulses. J Magn Reson 2001;152(1): 109-123
4. Szomolanyi P, Goodyear D, Balcom B, Matheson D, SPIRAL-SPRITE: a rapid single point MRI technique for application to porous media. Magn Reson Imaging 2001;19(3/4):423-428
5. Fang Z, Hoepfel D, Winter K, Application of single point imaging (SPI) to solid state materials. Magn Reson Imaging 2001;19(3/4):501-503
6. Capuani S, Alesiani M, Alessandri FM, Maraviglia B, Characterization of porous media structure by nonlinear NMR methods. Magn Reson Imaging 2001;19(3/4):319-323
7. Sendhil VS, Narasimhan PT, Jacobs RE, MR imaging with phase encoding of intermolecular multiple quantum coherences. J Magn Reson 2001;152(1):189-194
8. Ross A, Schlotterbeck G, Senn H, Von Kienlin M, Application of chemical shift imaging for simultaneous and fast acquisition of NMR spectra on multiple samples. Angew Chem Int Ed 2001; 40(17):3243-3245
9. Pohmann R, Von Kienlin M, Accurate phosphorus metabolite images of the human heart by 3D acquisition-weighted CSI. Magn Reson Med 2001;45(5):817-826
10. Lloyd CH, Scrimgeour SN, Chudek JA, Hunter G, MacKay RL, The application of magnetic resonance microimaging to the visible light curing of dental resins. Part 2. Dynamic imaging by the FLASH-MOVIE pulse sequence. Dent Mater 2001;17(2):170-177
11. 3+ contrast agents. J Phys Chem A 2001;105(41):9323-9327
12. Demco DE, Blumich B, NMR imaging of materials. Curr Opin Solid State Mater Sci 2001;5(2-3): 195-202
13. 1H NMR spectroscopy. Magn Reson Med 2001;45(5):741-748
14. Wedeen VJ, Reese TG, Napadow VJ, Gilbert RJ, Demonstration of primary and secondary muscle fiber architecture of the bovine tongue by diffusion tensor magnetic resonance imaging. Biophys J 2001;80(2):1024-1028
15. Sederman AJ, Gladden LF, MRI as a probe of the deposition of solid fines in a porous medium. Magn Reson Imaging 2001;19(3/4):565-567
16. Mantle MD, Bijeljic B, Sederman AJ, Gladden LF, MRI velocimetry and lattice-Boltzmann simulations of viscous flow of a Newtonian liquid through a dual porosity fibre array. Magn Reson Imaging 2001;19(3/4):527-529
17. Stepisnik J, Callaghan PT, Low-frequency velocity correlation spectrum of fluid in a porous media by modulated gradient spin echo. Magn Reson Imaging 2001;19(3/4):469-472
18. Moser KW, Kutter EC, Georgiadis JG, Buckius RO, Morris HD, Torczynski JR, Velocity measurements of flow through a step stenosis using magnetic resonance imaging. Exp Fluids 2000; 29(5):438-447
19. Tallarek U, Scheenen TWJ, Adrie de Jager P, Van As H, Using NMR displacement imaging to characterize electroosmotic flow in porous media. Magn Reson Imaging 2001;19(3/4):453-456
20. Peuke AD, Rokitta M, Zimmermann U, Schreiber L, Haase A, Simultaneous measurement of water flow velocity and solute transport in xylem and phloem of adult plants of Ricinus communis over a daily time course by nuclear magnetic resonance spectrometry. Plant Cell Environ 2001;24(5): 491-503
21. Kockenberger W, Functional imaging of plants by magnetic resonance experiments. Trends Plant Sci 2001;6(7):286-292
22. Witjes H, Simonetti AW, Buydens L, Better brain imaging with chemometrics. Anal Chem 2001; 73(19):548A-556A
23. Vicente MGH, Porphyrin-based sensitizers in the detection and treatment of cancer: recent progress. Curr Med Chem: Anti-Cancer Agents 2001; 1(2):175-194
24. Stein EA, fMRI: a new tool for the in vivo localization of drug actions in the brain. J Anal Toxicol 2001;25(5):419-424
25. Artemov D, Solaiyappan M, Bhujwalla ZM, Magnetic resonance pharmacoangiography to detect and predict chemotherapy delivery to solid tumors. Cancer Res 2001; 61(7):3039-3044
26. Ludemann L, Hamm B, Zimmer C, Pharmacokinetic analysis of glioma compartments with dynamic Gd-DTPA-enhanced magnetic resonance imaging. Magn Reson Imaging 2000;18(10): 1201-1214
27. Amorino GP, Lee H, Holburn GE, et al., Enhancement of tumor oxygenation and radiation response by the allosteric effector of hemoglobin, RSR13. Radiat Res 2001;156(3):294-300
28. Toronov VY, Webb A, Choi JH, Wolf M, Gratton E, Simultaneous assessment of human brain functional hemodynamics by magnetic resonance and near-infrared imaging. Proc SPIE-Int Soc Opt Eng 2001;4320:861-867
29. Toronov VY, Webb A, Choi JH, et al., Investigation of human brain hemodynamics by simultaneous near-infrared spectroscopy and functional magnetic resonance imaging. Med Phys 2001; 28(4):521-527
30. Martin WRW, Magnetic resonance imaging and spectroscopy in Parkinson's disease. Adv Neurol 2001;86:197-203
31. 1H magnetic resonance spectroscopic imaging: comparison with maps of metabolites. Cancer Res 2001;61(17):6524-6531
32. Callot V, Canet E, Brochot J, et al., Vascular and perfusion imaging using encapsulated laserpolarized helium. Magn Reson Mater Phys Biol Med 2001;12(1):16-22
33. Potter K, Butler JJ, Horton WE, Spencer RGS, Response of engineered cartilage tissue to biochemical agents as studied by proton magnetic resonance microscopy. Arthritis Rheum 2000; 43(7):1580-1590
34. Yoshioka H, Lang P, Ikeda K, Niitsu M, Itai Y, Preliminary trial of three-dimensional waterexcitation magnetization transfer contrast MR imaging of articular cartilage. Nippon Igaku Hoshasen Gakkai Zasshi 2001;61(10):545-547
35. Berg A, Ertl A, Moser E, High resolution polymer gel dosimetry by parameter selective MR-microimaging on a whole body scanner at 3T. Med Phys 2001;28(5):833-843
36. Louie AY, Huber MM, Ahrens ET, et al., In vivo visualization of gene expression using magnetic resonance imaging. Nature Biotech 2000;18: 321-325
37. Bell JD, Taylor-Robinson SD, Assessing gene expression in vivo: magnetic resonance imaging and spectroscopy. Gene Ther 2000;7(15):1259-1264
38. Meade TJ, Seeing is believing: monitoring in vivo gene expression by magnetic resonance imaging. Int Congress Ser 2000;1205:73-76
39. Louie AY, Meade TJ. Recent advances in MRI: novel contrast agents shed light on in vivo biochemistry, In: Wilson E, editor. New Technol Life Sci Trends Guide, Oxford, UK: Elsevier Science Ltd.; 2000, p 7-11
40. 3+ magnetic resonance imaging contrast agents with a prominent receptor-induced magnetization enhancement. Angew Chem Int Ed 2001;40(15):2903-2906
41. Lewin M, Clement O, Belguise-Valladier P, et al., Hepatocyte targeting with Gd-EOB-DTPA: Potential application for gene therapy. Invest Radiol 2001;36(1):9-14
42. Ward KM, Aletas AH, Balaban RS, A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J Magn Reson 2000;143:79-87
43. Zhang S, Winter P, Wu K, Sherry AD, A novel Europium(III)-based MRI contrast agent. J Am Chem Soc 2001;123:1517-1518
44. 3+ complexes with slowly exchanging bound-water molecules may offer advantages in the design of responsive MR agents. Invest Radiol 2001;36(2):82-86
45. Hovland R, Glogard C, Aasen AJ, Klaveness J, Gadolinium DO3A derivatives mimicking phospholipids; preparation and in vitro evaluation as pH responsive MRI contrast agents. J Chem Soc, Perkin Trans 2 2001;(6):929-933
46. Yushmanov VE. Relaxation phenomena in biomedical applications of NMR, In: Atta-ur-Rahman, editor. New Adv Anal Chem, Amsterdam: Harwood Academic Publishers; 2000, p 569-604
47. Jackson EF, Principles of magnetic resonance imaging and magnetic resonance spectroscopy. In: Kim EE, Yang DJ, editors. TargetedMol Imaging Oncol, Secaucus, NJ: Springer-Verlag New York; 2001, p 30-61
48. Saeed M, New concepts in characterization of ischemically injured myocardium by MRI. Exp Biol Med 2001;226(5):367-376
49. Csernansky JG, Structural MRI as a tool for the study of neurotoxicity and neurodegenerative disorders. J Anal Toxicol 2001;25(5):414-418
50. Torchilin V, Babich J, Weissig V, Liposomes and micelles to target the blood pool for imaging purposes. J Liposome Res 2000;10(4):483-499
51. Tanimoto A, Magnetic resonance imaging with superparamagnetic nanocapsules. Microspheres Microcapsules Liposomes 2001;3:525-558
52. Tanimoto A, Liver-specific MR contrast agents: current status and prospects. Nippon Igaku Hoshasen Gakkai Zasshi 2001;61(10):525-533
53. Toth E, Burai L, Merbach AE, Similarities and differences between the isoelectronic Gd(III) and Eu(II) complexes with regard to MRI contrast agent applications. Coord Chem Rev 2001; 216-217, 363-382
54. Mahfouz A-E, MS-325 EPIX. Curr Opin Invest Drugs 2000;1(4):476-480
55. Ni Y, Adzamli K, Miao Y, et al., MRI contrast enhancement of necrosis byMP-2269 and gadophrin-2 in a rat model of liver infarction. Invest Radiol 2001;36(2):97-103
56. Jendrasiak GL, Smith RL, Ribeiro AA, The interaction of MRI contrast agents with phospholipids. Phys Med Biol 2000;45(10):3109-3122
57. Pascolo L, Petrovic S, Cupelli F, et al., ABC protein transport of MRI contrast agents in canalicular rat liver plasma vesicles and yeast vacuoles. Biochem Biophys Res Commun 2001;282(1):60-66
58. Colet J-M, Lecomte S, Vander Elst L, Muller RN, Cesium-133: a potential reporter of the hepatic uptake of contrast agents. Magn Reson Med 2001;45(4):711-715
59. Toft KG, Myrset AH, Skotland T, Dephosphorylation ofMnDPDP and related compounds by acid and alkaline phosphatase. J Pharm Biomed Anal 2001;25(3-4):613-618
60. Laurent S, Vander L, Copoix F, Muller RN, Stability of MRI paramagnetic contrast media: a proton relaxometric protocol for transmetalation assessment. Invest Radiol 2001;36(2):115-122
61. Portet D, Denizot B, Rump E, Lejeune J-J, Jallet P, Nonpolymeric coatings of iron oxide colloids for biological use as magnetic resonance imaging contrast agents. J Colloid Interface Sci 2001; 238(1):37-42
62. Kim DK, Zhang Y, Kehr J, Klason T, Bjelke B, Muhammed M, Characterization and MRI study of surfactant-coated superparamagnetic nanoparticles administered into the rat brain. J Magn Magn Mater 2001;225(1-2):256-261
63. Kim DK, Zhang Y, Voit W, et al., Superparamagnetic iron oxide nanoparticles for bio-medical applications. Scr Mater 2001;44(8/9):1713-1717
64. Strable E, Bulte JWM, Moskowitz B, Vivekanandan K, Allen M, Douglas T, Synthesis and characterization of soluble iron oxidedendrimer composites. Chem Mater 2001;13(6): 2201-2209
65. Grimm J, Karger N, Lusse S, et al., Characterization of ultrasmall, paramagnetic magnetite particles as superparamagnetic contrast agents in MRI. Invest Radiol 2000;35(9):553-556
66. Ruehm SG, Corot C, Vogt P, Kolb S, Debatin JF, Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 2001;103(3):415-422
67. 64. Cancer Res 2001; 61(13):4966-4970
68. Kobayashi H, Sato N, Hiraga A, et al., 3D-micro-MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with reference to their pharmacokinetic properties. Magn Reson Med 2001;45(3): 454-460
69. Mikawa M, Kato H, Okumura M, et al., Paramagnetic water-soluble metallofullerenes having the highest relaxivity for MRI contrast agents. Bioconjugate Chem 2001;12(4):510-514
70. Anelli PL, Beltrami A, Franzini M, et al., Gd(III) complexes of poly(hydroxymethyl)substituted derivatives of 1,4,7,10-tetraazacyclododecane-1,4,7, 10-tetraacetic acid. Inorg ChimActa 2001;317(1,2): 218-229